3652 results for «303»
3652 results
Coronary access after TAVI, a growing need
20 May 2021 – From EuroPCR 2021
Watch this session presented by Nicolas Van Mieghem, Christopher Meduri, Andreas Ruck, Nawzad Saleh, Joanna Wykrzykowska and Mohamed Abdel-Wahab in order to learn about the growing importance of coronary access after TAVI, to understand how TAVI design and implantation technique has an impact on future coronary access, and to discuss the...
Why physiology and co-reg is helpful in treating patients with multivessel disease/diffused disease
20 May 2021 – From EuroPCR 2021
Watch this session presented by Sukhjinder Nijjer, Nick Curzen, Rasha Al-Lamee and Sayan Sen in order to learn about the new pressure guide wire OmniWire and workflow enhancement with Azurion and IntraSight, to understand how "interventional physiology" can guide PCI in diffuse, multivessel coronary artery disease, and to learn how...
Sustained Limus release, redefining indications for drug-eluting balloons
20 May 2021 – From EuroPCR 2021
Watch this session presented by Bernardo Cortese, Kambis Mashayekhi, Jonas Häner and Tuomas Rissanen in order to understand how sustained Limus release technology can broaden DEB indications, to learn how SELUTION SLR sustained Limus DEB performs in daily clinical practice, and to know more about the importance of sustained Limus release technology...
Latest insights: when to choose orbital atherectomy
20 May 2021 – From EuroPCR 2021
Watch this session presented by Nicolas Van Mieghem, Surendra Avula and Ajay Kirtane in order to understand the challenges of treating severe calcium, to know about the OAS overview with dual-action MOA technology and the clinical evidence supporting its use, and to be introduced to treatment technique.
TAVI in a patient with coronary artery disease - Session with LIVE demonstration
18 May 2021 – From EuroPCR 2021
Watch this session if you want to discuss the available data for treating coronary artery disease in patients undergoing TAVI and to understand the role of FFR/IFR in coronary artery disease assessment prior to TAVI.
This session was originally presented during EuroPCR 2021.
Left Main and bifurcation PCI - Session with LIVE demonstration
19 May 2021 – From EuroPCR 2021
Watch this session if you want to understand how to adapt your treatment strategy to the underlying anatomy, to learn the steps of provisional left main PCI and to discuss the pitfalls of provisional left main PCI.
This session was originally presented during EuroPCR 2021.
How to prevent and manage coronary perforation?
19 May 2021 – From EuroPCR 2021
Watch this session if you want to learn about the different types of coronary perforation, to discuss how to predict which situations and coronary anatomies are particularly at risk of coronary perforation, and to share practical tips for rapid and effective management of coronary perforation.
This session...
EuroPCR 2021 Hotlines / Late-Breaking Trials in renal denervation: EFFECTIVENESS
25 May 2021 – From EuroPCR 2021
Find out more about the EFFECTIVENESS trial regarding renal denervation.
Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial
20 Sep 2022
Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.
It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...
Author
3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications
22 Mar 2022
Ali Nazmi Calik provides his take on the long-term results of the SPYRAL HTN-ON MED trial which demonstrated the durable efficacy and safety of RDN in patients who are already on one to three antihypertensive drugs.
Author
INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes
03 Sep 2024
Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.
Author
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR
29 Mar 2025
Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.
Author
Author
